S&P 500   4,438.94 (-0.37%)
DOW   34,891.38 (+0.27%)
QQQ   369.48 (-1.03%)
AAPL   145.07 (-1.26%)
MSFT   293.57 (-1.93%)
FB   351.46 (-0.42%)
GOOGL   2,816.32 (-0.98%)
TSLA   796.48 (+2.85%)
AMZN   3,373.84 (-1.51%)
NVDA   215.76 (-2.29%)
BABA   148.72 (+2.51%)
NIO   36.51 (+3.19%)
CGC   14.65 (+5.32%)
GE   105.90 (+2.02%)
MU   75.28 (+1.66%)
AMD   107.30 (+1.42%)
T   27.55 (+1.55%)
F   14.25 (+3.41%)
ACB   6.35 (+6.72%)
DIS   179.00 (+1.70%)
PFE   43.73 (-0.48%)
BA   226.20 (+2.17%)
BAC   43.34 (+2.85%)
S&P 500   4,438.94 (-0.37%)
DOW   34,891.38 (+0.27%)
QQQ   369.48 (-1.03%)
AAPL   145.07 (-1.26%)
MSFT   293.57 (-1.93%)
FB   351.46 (-0.42%)
GOOGL   2,816.32 (-0.98%)
TSLA   796.48 (+2.85%)
AMZN   3,373.84 (-1.51%)
NVDA   215.76 (-2.29%)
BABA   148.72 (+2.51%)
NIO   36.51 (+3.19%)
CGC   14.65 (+5.32%)
GE   105.90 (+2.02%)
MU   75.28 (+1.66%)
AMD   107.30 (+1.42%)
T   27.55 (+1.55%)
F   14.25 (+3.41%)
ACB   6.35 (+6.72%)
DIS   179.00 (+1.70%)
PFE   43.73 (-0.48%)
BA   226.20 (+2.17%)
BAC   43.34 (+2.85%)
S&P 500   4,438.94 (-0.37%)
DOW   34,891.38 (+0.27%)
QQQ   369.48 (-1.03%)
AAPL   145.07 (-1.26%)
MSFT   293.57 (-1.93%)
FB   351.46 (-0.42%)
GOOGL   2,816.32 (-0.98%)
TSLA   796.48 (+2.85%)
AMZN   3,373.84 (-1.51%)
NVDA   215.76 (-2.29%)
BABA   148.72 (+2.51%)
NIO   36.51 (+3.19%)
CGC   14.65 (+5.32%)
GE   105.90 (+2.02%)
MU   75.28 (+1.66%)
AMD   107.30 (+1.42%)
T   27.55 (+1.55%)
F   14.25 (+3.41%)
ACB   6.35 (+6.72%)
DIS   179.00 (+1.70%)
PFE   43.73 (-0.48%)
BA   226.20 (+2.17%)
BAC   43.34 (+2.85%)
S&P 500   4,438.94 (-0.37%)
DOW   34,891.38 (+0.27%)
QQQ   369.48 (-1.03%)
AAPL   145.07 (-1.26%)
MSFT   293.57 (-1.93%)
FB   351.46 (-0.42%)
GOOGL   2,816.32 (-0.98%)
TSLA   796.48 (+2.85%)
AMZN   3,373.84 (-1.51%)
NVDA   215.76 (-2.29%)
BABA   148.72 (+2.51%)
NIO   36.51 (+3.19%)
CGC   14.65 (+5.32%)
GE   105.90 (+2.02%)
MU   75.28 (+1.66%)
AMD   107.30 (+1.42%)
T   27.55 (+1.55%)
F   14.25 (+3.41%)
ACB   6.35 (+6.72%)
DIS   179.00 (+1.70%)
PFE   43.73 (-0.48%)
BA   226.20 (+2.17%)
BAC   43.34 (+2.85%)
OTCMKTS:TRSSF

TerrAscend Stock Forecast, Price & News

$7.13
+0.05 (+0.68 %)
(As of 09/24/2021 04:00 PM ET)
Add
Compare
Today's Range
$6.82
$7.27
50-Day Range
$6.57
$9.16
52-Week Range
$4.02
$16.25
Volume292,900 shs
Average Volume337,674 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive TRSSF News and Ratings via Email

Sign-up to receive the latest news and ratings for TerrAscend and its competitors with MarketBeat's FREE daily newsletter.


TerrAscend logo

About TerrAscend

TerrAscend Corp. produces and sells medical cannabis products. The firm owns several businesses and brands, including The Apothecarium, Ilera Healthcare, Kind Tree, Prism, State Flower, Valhalla Confections, and Arise Bioscience Inc. The company was founded by Basem Hanna, Vijay Sappani and Michael Nashat on March 7, 2017 and is headquartered in Mississauga, Canada.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:TRSSF
CIK
N/A
Employees
N/A
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A

Profitability

Debt

Price-To-Earnings

Miscellaneous

Next Earnings Date
11/17/2021 (Estimated)
Optionable
Not Optionable

MarketRank

Overall MarketRank

1.90 out of 5 stars

Analyst Opinion: 4.5Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












TerrAscend (OTCMKTS:TRSSF) Frequently Asked Questions

Is TerrAscend a buy right now?

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for TerrAscend in the last year. There are currently 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" TerrAscend stock.
View analyst ratings for TerrAscend
or view top-rated stocks.

What stocks does MarketBeat like better than TerrAscend?

Wall Street analysts have given TerrAscend a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but TerrAscend wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting TerrAscend?

TerrAscend saw a increase in short interest in the month of August. As of August 31st, there was short interest totaling 512,300 shares, an increase of 110.7% from the August 15th total of 243,100 shares. Based on an average daily trading volume, of 683,200 shares, the days-to-cover ratio is presently 0.7 days.
View TerrAscend's Short Interest
.

When is TerrAscend's next earnings date?

TerrAscend is scheduled to release its next quarterly earnings announcement on Wednesday, November 17th 2021.
View our earnings forecast for TerrAscend
.

How were TerrAscend's earnings last quarter?

TerrAscend Corp. (OTCMKTS:TRSSF) released its quarterly earnings results on Wednesday, August, 18th. The company reported ($0.14) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of $0.03 by $0.17.
View TerrAscend's earnings history
.

How has TerrAscend's stock price been impacted by Coronavirus?

TerrAscend's stock was trading at $1.8277 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, TRSSF shares have increased by 289.9% and is now trading at $7.1262.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for TRSSF?

7 equities research analysts have issued twelve-month target prices for TerrAscend's stock. Their forecasts range from $8.65 to $24.00. On average, they expect TerrAscend's share price to reach $15.33 in the next year. This suggests a possible upside of 115.1% from the stock's current price.
View analysts' price targets for TerrAscend
or view top-rated stocks among Wall Street analysts.

Who are TerrAscend's key executives?

TerrAscend's management team includes the following people:
  • Keith Stauffer, Chief Financial Officer
  • Daniel Foley, Treasurer & Senior Vice President
  • Ari Unterman, Vice President-Business Development
  • Halligan Joanna, Vice President-Human Resources
  • Jason M. Marks, Chief Legal Officer

What is TerrAscend's stock symbol?

TerrAscend trades on the OTCMKTS under the ticker symbol "TRSSF."

How do I buy shares of TerrAscend?

Shares of TRSSF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is TerrAscend's stock price today?

One share of TRSSF stock can currently be purchased for approximately $7.13.

What is TerrAscend's official website?

The official website for TerrAscend is www.terrascend.com.

Where are TerrAscend's headquarters?

TerrAscend is headquartered at PO Box 43125, Mississauga, ON L5B.

How can I contact TerrAscend?

TerrAscend's mailing address is PO Box 43125, Mississauga, ON L5B. The company can be reached via phone at (855) 837-7295.


This page was last updated on 9/27/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.